Fact CheckerSign in

NCT06417307CompletedPhase 3

Exercise on Mitochondrial Functions of Lymphocyte in Hemodialysis

Supervised Exercise Therapy on Mitochondrial Functions of Platelet and Lymphocyte in Patients With End-Stage Renal Disease on Hemodialysis

Source: ClinicalTrials.gov · Last updated 4 Apr 2025

Brief summary (registry, in English)

To improve aerobic capacity, muscular function and health-related quality of life in patients with end-stage renal disease (ESRD), regular exercise is recommended. Supervised intradialytic exercise with moderate intensity is an available approach to maintain patients' safety and compliance, and enhance physiological adaptations effectively. The exercise training effects of mitochondrial functions of lymphocyte in ESRD patients, like respiratory capacity, bioenergetic status and thrombosis/immunological regulation remained unclear. Method: ESRD patients (anticipated n=180) would conduct supervised exercise training therapy for 3 days a week for 6 months in the hospital and 3 months at home. Cardiopulmonary exercise therapy would be performed before and after the intervention. A high resolution respirometer and a flow cytometer are used to determine the oxygen consumption rate/mitochondrial respiration in mitochondria and subtypes of lymphocyte, respectively.

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
180 (actual)
First submitted
13 May 2024
Start date
1 Aug 2021
Primary completion date
31 Jul 2024
Lead sponsor
Chang Gung Memorial Hospital
NCT number
NCT06417307

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 180
  • From 1 Aug 2021 to the primary completion date, 31 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Under 20 years-old, hyperkalemia occurs within 3 month, orthopedic or muscular diseases, other medical, psychological or physiological diseases, pregnancy exercise contraindications.

Who the study is looking for

  • All patients have been receiving hemodialysis and medication at least for 6 weeks, the Kt/V score must be above 1.2 to show that they were stable.

Age in the registry: 20 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chang Gung University
Coordinator of this site? Confirm its status
TaoyuanTaiwanUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.